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ardiac fibrosis is a common pathological process in numerous forms of heart disease and manifests as excessive deposition of extracellular matrix (ECM), increase of collagen content, and imbalanced synthesis and arrangement of various types of ECM proteins. 1 Cardiac myofibroblasts, differentiated from resident or circulation-derived fibroblasts, are not only principal ECM producers but also responders to proinflammatory cytokines including tumor necrosis factor-a (TNF-a), interleukin (IL)-1, IL-6, transforming growth factor-b (TGF-b); vasoactive peptide angiotensin II (Ang II), endothelin-1; and hormones such as norepinephrine. 2 Ang II, the key effector of the renin-angiotensin system, plays a central role in cardiac fibrosis through hemodynamic-dependent and -independent mechanisms, which evoke an inflammatory microenvironment in the hypertensive heart and promote the differentiation of infiltrated monocytes into myofibroblasts. 3 A thorough understanding of the underlying mechanism of Ang II-induced cardiac fibrosis may help in fibrosis prevention and treatment.
Intermediate-conductance Ca 2+ -activated K + (K Ca 3.1) channels regulate the membrane potential and calcium entry into cells, thereby modulating calcium signaling-regulated processes. Previous studies have shown that K Ca 3.1 channels are closely involved in regulation of cell cycle, cell phenotypic modulation, proliferation, and migration. [4] [5] [6] [7] K Ca 3.1 channels also contribute to activation of inflammatory cells. 8 With regard to organ fibrosis, K Ca 3.1 channels play a pivotal role in renal fibrosis. 9 K Ca 3.1 channels are also regarded as a However, the role and molecular mechanism of K Ca 3.1 channels in cardiac fibrosis remain unclear.
The differentiation of cardiac fibroblasts to more active myofibroblasts is the hallmark of cardiac fibrosis, as characterized by increased collagen production and expression of asmooth muscle actin (a-SMA). 11 There is a growing list of transient receptor potential (TRP) cation channels associated with cellular differentiation including the conversion of fibroblasts into myofibroblasts. Most of the TRP channels are activated by a variety of ligands, the mechanical environment, and/or changes in internal Ca 2+ stores. Cardiac fibroblasts utilize a Ca 2+ signal from these channels to transform quiescent fibroblasts into myofibroblasts. Of those channels TRPV4 and TRPC6 have been linked to myofibroblast differentiation. 12 K Ca 3.1 channels can regulate cell membrane potential and then influence Ca 2+ entry. Whether K Ca 3.1 channels interact with TRPV4 and TRPC6 channels and modulate the differentiation of fibroblasts into myofibroblasts needs to be investigated. We previously showed that, in fibroblasts isolated from rat hearts, both mRNA and protein expression of K Ca 3.1 channels are upregulated when treatment with Ang II activates Ang II type I receptors. Inhibition of K Ca 3.1 channels with the specific blocker TRAM-34 or small interfering RNA (siRNA) suppresses Ang II-stimulated fibroblast proliferation and collagen synthesis and secretion. 13 Furthermore, treatment with TRAM-34 in vivo effectively attenuates cardiac fibrosis induced by abdominal aortic constriction and reduces the expression of leukocyte differentiation antigens CD45 and CD3, macrophage-specific antigen F4/80, TNF-a, and monocyte chemotactic protein 1 (MCP-1) in the myocardium. 14 In addition, our in vitro investigation demonstrates that blockade of K Ca 3.1 channels abrogates Ang II-induced monocyte transendothelium migration and reduces the synthesis and release of MCP-1 by endothelial cells. 14 These findings suggest that K Ca 3.1 channels are involved in Ang II-mediated inflammatory and fibrotic signaling.
In the present study, we hypothesized that K Ca 3.1 channels could facilitate cardiac fibrosis through mediating the recruitment of bone marrow-derived monocytes to the myocardium, where they differentiate into myofibroblasts under an inflammatory microenvironment induced by Ang II. Using the established cardiac fibrosis model in rats by Ang II infusion, we observed that treatment with TRAM-34 significantly attenuated cardiac fibrosis and the inflammatory reaction as well as the number of fibroblast precursor cells and myofibroblasts. By separating circulating mononuclear cells from male adult healthy rats and CD4 + T cells from male adult healthy mice, we observed that inhibition of K Ca 3.1 channels suppressed Ang II-stimulated expression and secretion of IL-4 and IL-13 in CD4 + T cells and IL-4-or IL-13-induced differentiation of monocytes into fibrocytes. Our results provide novel evidence for the role and mechanism of K Ca 3.1 channels in cardiac fibrosis.
Methods
The data, analytic methods, and study materials will be available from the corresponding author on reasonable request to other researchers for purposes of reproducing the results or replicating the procedure.
Rat Model of Ang II Infusion-Induced Cardiac Fibrosis
All animals were obtained from the Laboratory Animal Centre of Xi'an Jiaotong University (Xi'an, China • Our study demonstrated that K Ca 3.1 channels facilitate myocardial inflammation and differentiation of bone marrow-derived monocytes into myofibroblasts, thereby promoting cardiac fibrosis caused by angiotensin II infusion.
• We found an interaction between K Ca 3.1 and TRPV4/TRPC6 channels in cardiac fibroblasts that contributed to the differentiation of fibroblasts into myofibroblasts.
What Are the Clinical Implications?
• These findings elucidate the role and mechanism of K Ca 3.1 channels in the development and progression of cardiac fibrosis.
• The study also provides valuable insights into the K Ca 3.1 channel as a therapeutic target to prevent cardiac fibrosis.
Taimeng Company, Sichuan, China). Four weeks after Ang II infusion the rats were anesthetized with sodium pentobarbital (45 mg/kg intraperitoneally), and blood was collected from the abdominal aorta. The hearts were isolated and weighed to calculate the heart-weight/body-weight ratio. The concentration of hydroxyproline in the myocardium of the left ventricle (LV) was measured by enzyme-linked immunosorbent assay (ELISA) following the manufacturer's protocol. In brief, 20-mg LV tissue samples in 0.2 mL PBS were homogenized with a tissue homogenizer, and the homogenates were centrifuged at 3000g for 10 minutes at 4°C. The supernate was collected to assay hydroxyproline level immediately.
Echocardiography
Transthoracic echocardiography was performed as described previously by using a Vevo 2100 ultrasound machine (Visualsonics Inc, Toronto, Canada) with a 21-MHz transducer. 16 Animals were maintained under light anesthesia by inhalation of 1.8% isoflurane and placed on a heating pad. A 2-dimensional image of the LV was obtained at a level of the papillary muscles, and a 2-dimensional guided M-mode trace crossing the anterior and posterior walls was recorded at sweep speed of 100 mm/s. The following parameters were measured in a blinded fashion on the M-mode tracings using the leading-edge technique: LV internal dimensions (LVID) at diastole and systole, LV mass, and ejection fraction. Fractional shortening was calculated as (LVID diastole ÀLVID systole )/LVID diastole . Measurements were taken from 5 cardiac cycles, and the averages were used.
Isolation of Cardiac Fibroblasts and Electrophysiology
After 4 weeks' intervention, the hearts from each group of rats were quickly excised and placed in cold PBS. Ventricular fibroblasts were isolated by standard collagenase digestion methods, as we previously described. 13 Cells were cultured in DMEM with 5 mmol/L glucose (Gibco, ThermoFisher, Walthm, MA)) with 10% fetal bovine serum (Invitrogen, Carlsbad, CA), penicillin (100 U/mL), and streptomycin (100 mg/mL) incubated at 37°C in a humidified atmosphere with 5% CO 2 . After growing to the fusion status, cells were detached and seeded in CC2 glass slides for immunofluorescent double staining or 1-mL cell chambers for electrophysiology. Membrane current was recorded with the whole-cell patch-clamp technique at room temperature (22°C to 23°C) as described previously.
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Mouse CD4 + T-Cell Isolation and Culture
Splenocytes were isolated according to the protocol of Ismahil et al. 18 Briefly, male C57BL/6 mice (n=30) were anesthetized with sodium pentobarbital (50 mg/kg intraperitoneally), and spleens were harvested. A splenic cell suspension was prepared by grinding spleens with a push rod of a 2-mL syringe in PBS and passed through a 100-lm nylon cell strainer (BD Falcon, Durham, NC). Red blood cell lysis was conducted using red blood cell lysate buffer (Gibco 
Rat Peripheral Blood Monocyte Isolation and Fibrocyte Differentiation
Peripheral blood anticoagulated with dipotassium EDTA was collected from healthy adult male rats. PBMCs were isolated by Ficoll-Hypaque gradient centrifugation (Hao-Yang, Tianjin, China) following the manufacturer's protocol and incubated in serum-free medium, which consists of FibroLife (LM-0001, Lifeline Cell Technology, Walkersville, MD) supplemented with 20 mmol/L HEPES, 29ITS+3, 29nonessential amino acids, 2 mmol/L sodium pyruvate, 4 mmol/L glutamine (Invitrogen, Carlsbad, CA), 100 U/mL penicillin, and 100 lg/mL streptomycin. 20 PBMCs were cultured in CC2 glass slides at 2.5910 5 cells/mL with or without 3 ng/mL rat recombinant IL-4 or IL-13 (Peprotech, Rocky Hill, NJ) and 3 ng/mL rat recombinant IL-4 or IL-13 plus 1 lmol/L TRAM-34 in a humidified incubator containing 5% CO 2 at 37°C for 5 days. Then the detachable upper medium chamber was removed, and cells were stained by immunocytochemistry to identify the differentiated fibrocytes.
Immunohistochemistry and Immunocytochemistry
Myocardial tissue was fixed in formalin and then embedded in paraffin. Deparaffined sections (5 lm in thickness) were stained with Masson trichrome reagent. Images were digitized (9400 magnification, 6 fields per heart) under a microscope (DP72; Olympus, Tokyo, Japan). The expression of CD45, CD3, CD68, TNF-a, MCP-1, collagen I, and collagen III in the myocardium was immunolocalized using anti-CD45 antibody 
Immunofluorescent Double Staining
For immunofluorescent double staining, deparaffinized sections were fixed in 100% cold methanol, and nonspecific proteins were blocked with 1% bovine serum albumin. The sections were incubated with rabbit anti-rat CD45 antibody (1:200) and mouse anti-rat CD34 antibody (1:200), rabbit anti-rat DDR-2 antibody (1:200), and mouse anti-rat CD11b antibody (1:200) or rabbit anti-rat DDR-2 antibody (1:200) and mouse anti-rat a-SMA antibody (1:200) at 4°C overnight. After the incubation with appropriate fluorescence-labeled secondary antibody at room temperature for 1 hour, the sections were observed under a fluorescence microscope (DP72; Olympus, Tokyo, Japan).
Isolated cardiac fibroblasts were seeded in 8-well glass slides for 1 night; after adherence, the chamber on the slides was removed, and cells were stained by immunofluorescent double staining. Cells were fixed in 100% cold methanol, and nonspecific proteins were blocked with 1% bovine serum albumin. Then slides were incubated with mouse anti-rat K Ca 3.1 antibody (1:200) and goat anti-rat TRPV4 antibody (1:200) or mouse anti-rat K Ca 3.1 antibody (1:200) and goat anti-rat TRPC6 antibody (1:200) at 4°C overnight. After the incubation with appropriate fluorescence-labeled secondary antibody at room temperature for 1 hour, the slides were observed under a confocal microscope (A1R; Nikon, Chiyoda, Japan).
Electrophysiology
Membrane current was recorded in primary rat cardiac fibroblasts, which were isolated from 4-week-intervened rats, with the whole-cell patch-clamp technique. The detached cardiac fibroblasts were placed into a 1-mL cell chamber mounted on an inverted microscope (Diaphot; Nikon, Japan), allowed to settle to the bottom (2 hours), and then superfused with Tyrode solution (pH 7.4) that contained (mmol/L) 136 NaCl, 5.4 KCl, 1 MgCl 2 , 1.8 CaCl 2 , 10 glucose, and 10 HEPES. Borosilicate glass electrodes (1.2-mm outer diameter) were pulled with a Brown Flaming puller (Model P-97; Sutter Instrument Co, Novato, CA), and had a resistance of 2 to 3 MΩ when filled with pipette solution that contained (mmol/L) 120 K-aspartate, 20 KCl, 1 MgCl 2 , 5 EGTA, 5 Na-phosphocreatine, 5 Mg-ATP, 0.1 GTP, 10 HEPES, 800 nmol/L free Ca 2+ with pH adjusted to 7.2 with KOH. The tip potentials were zeroed before the pipette contacted the cell. After a gigaohm seal was obtained by negative suction, the cell membrane was ruptured by a gentle suction to establish a whole-cell configuration. Membrane currents were recorded with an Axopatch 200B amplifier (Axon Instruments, Union City, CA), filtered at 2 kHz using a low-pass Bessel filter, digitized at 10 kHz, and stored in the hard disk of an IBM-compatible computer for subsequent analysis with Clampfit 9.0 (Molecular Devices, Sunnyvale, CA). All current recording experiments were conducted at room temperature (22°C to 23°C).
Western Blotting Analysis
The expression of inflammation-and fibrosis-related markers in the myocardium and the expression of IL-4 and IL-13 in CD4 + T cells were determined by Western blotting analysis with the procedure as described previously. 21 Immunodetection was performed by overnight incubation with primary antibodies for anti-collagen I (1:500), anti-collagen III (1:500), anti-connective tissue growth factor (CTGF) (1:500), anti-TGF-b (1:500), anti-CD45 (1:500), anti-CD3
(1:1000), anti-CD68 (1:1000), anti-TNF-a (1:500), anti-MCP-1 (1:1000), anti-IL-4 (1:500), and anti-IL-13 (1:500) at 4°C and then incubated with horseradish peroxidaseconjugated secondary antibodies (1:5000) for 1 hour at room temperature. The bound antibodies were detected with an enhanced chemiluminescence detection system (Bio-Rad, Hercules, CA) and quantified by densitometry using the Chemi-Genius Bio-Imaging System (Syngene, Cambridge, UK). To ensure equal sample loading, the ratio of band intensity to b-actin was obtained to quantify the relative protein expression level.
Statistical Analysis
All data obeyed normal distribution characteristics and were presented as meansAESEM. To ensure the establishment of cardiac remodeling induced by Ang II, we evaluated the alterations of blood pressure, heartweight/body-weight ratio, and cardiac function of rats. One week after Ang II infusion, rats exhibited a significant rise of SBP, and the increment remained to the end of the experiment.
Three-week treatment with 80 mg/kg TRAM-34, a specific K Ca 3.1 channel blocker, attenuated the increase of SBP induced by Ang II, and this effect of TRAM-34 was maintained during the experiment ( Figure 1A ). The SBP-lowering effect of TRAM-34 was possibly attributable to the reduction of renin, angiotensinogen, and endogenous Ang II levels in plasma and myocardium in accord with our previous study. 14 Compared with the control group, the heart-weight/body-weight ratio was significantly increased after Ang II infusion for 4 weeks, which was prevented by treatment with TRAM-34 ( Figure 1B) . Figure 1C shows typical echocardiographic tracing images in rats from different group. Group data confirmed the decrease of ejection fraction and fractional shortening and the increase of LVID diastole , LVID systole , and LV mass by Ang II infusion, and the effects of Ang II were attenuated by TRAM-34 treatment ( Figure 1D ). Expression of collagen I and collagen III in the LV myocardium was determined by immunohistochemistry staining and Western blotting analysis. The levels of collagen I and collagen III were increased significantly in the Ang II group compared with that of the control group and were reduced dramatically by administration of TRAM-34 ( Figure 2A and 2B) . Masson trichrome staining revealed that Ang II infusion caused significant collagen deposition in both interstitial and perivascular regions, which was reduced by TRAM-34 ( Figure 2C) . Consistent with the histological findings, TRAM-34 attenuated the increase of hydroxyproline concentration in the LV of the rats subjected to Ang II infusion for 4 weeks ( Figure 2D ).
CTGF and TGF-b are implicated as key molecules for fibrogenesis. Ang II infusion in rats significantly increased cardiac and plasma levels of CTGF and TGF-b, and this effect was partly reversed by TRAM-34 treatment ( Figure 2E and 2F). These findings indicate that K Ca 3.1 channels contribute to cardiac fibrosis induced by Ang II infusion.
K Ca 3.1 Channels Contribute to Ang II-Mediated Cardiac Inflammation
We then assessed whether K Ca 3.1 channels were involved in the process of hypertensive cardiac inflammation evoked by Ang II. Using immunohistochemistry and Western blotting, we observed increased expressions of MCP-1 and TNF-a as well as inflammatory cell markers, including CD45 (leukocyte), CD3 (T lymphocyte), and CD68 (macrophage) in the myocardium of Ang II-infusion rats ( Figure 3A and 3B) . Treatment with TRAM-34 reversed the increased expression of these proinflammatory factors and cell markers. Figure 3C displays the levels of MCP-1 and TNF-a measured by ELISA in the plasma of the rats. Ang II infusion increased the plasma concentration of MCP-1 but not the TNF-a, and this action was abolished by treatment with TRAM-34. These results confirmed the role of K Ca 3.1 channels in Ang II-evoked cardiac inflammation. Figure 4 illustrates the location of fibrocytes and their differentiation in rat myocardium by immunofluorescence double staining. Fibrocytes expressed cell markers of CD45 (leukocyte marker), CD34 (hematopoietic stem cell marker) ( Figure 4A ), CD11b (monocyte marker), and DDR-2 (fibroblast marker) (Figure 4B ), indicating that they were differentiated from bone marrow-derived monocytes. The myocardial density of these fibrocytes identified by the double staining was significantly higher in the Ang II-treated hearts and was reduced markedly, by %65%, by administration of TRAM-34. The immunofluorescent double staining of myofibroblast markers (a-SMA and DDR-2) in the rat myocardium was also enhanced by Ang II infusion and similarly reversed by TRAM-34 treatment ( Figure 4C) . The results implicate a role of K Ca 3.1 channels in promoting fibrocyte recruitment into the myocardium and subsequent differentiation into myofibroblasts, thereby contributing to Ang II-induced fibrosis.
Effect of K Ca 3.1 Channels on the Recruitment and Differentiation of Fibrocytes in Myocardium

Effect of K Ca 3.1 Channels on Ang II-Induced IL-4 and IL-13 Expression and Secretion
Using Western blotting and ELISA, we examined the role of K Ca 3.1 channels in IL-4 and IL-13 expression and secretion in Ang II-infusion rat plasma and isolated mouse CD4 + T cells.
Ang II infusion significantly increased the plasma levels of IL-4 and IL-13, which were suppressed by treatment with TRAM-34 ( Figure 5A ). These changes of T helper (Th)- 
K Ca 3.1 Channels and IL-4-or IL-13-Induced Differentiation of Monocytes Into Fibrocytes
To investigate whether K Ca 3.1 channels were involved in the differentiation of monocytes into fibrocytes mediated by IL-4 and IL-13, PBMCs from peripheral blood of healthy adult rats were isolated and cultured in serum-free medium. Fibrocytes were defined by morphology (adherent spindle-shaped cells with an oval nucleus) and by coexpression of CD34, collagen I, and DDR-2. As shown in Figure 6A and 6B, IL-4 and IL-13 facilitated the differentiation of monocytes into fibrocytes, and such action was reduced to 55% and 50% by blockade of K Ca 3.1 channels with 1 lmol/L TRAM-34 and downregulation of K Ca 3.1 channels with 100 nmol/L K Ca 3.1 siRNA, respectively ( Figure 6C ). The images of DDR-2 immunohistochemistry staining illustrated the effect of K Ca 3.1 siRNA on differentiation of monocytes into fibrocytes in myocardium ( Figure S3 ).
K Ca 3.1 Current in Primary Cardiac Fibroblasts Isolated From Ang II-Infusion Rats
We then investigated whether chronic Ang II stimulation altered K Ca 3.1 channel activity in rat cardiac fibroblasts. Using whole-cell patch clamp, we recorded the membrane currents in isolated rat cardiac fibroblasts with 300-millisecond voltage steps to between À100 and +100 mV from a holding potential of À70 mV (inset) ( Figure 7A ). The membrane current with weak inward rectification at more positive potentials was found to be inhibited by the K Ca 3.1 channel blocker TRAM-34 (1 lmol/L), suggesting that the K Ca 3.1 current was 1 of the predominant potassium-channel currents in primary cardiac fibroblasts. Importantly, the membrane current and the scale of its inhibition by TRAM-34 were significantly increased in primary cardiac fibroblasts prepared from rats receiving Ang II infusion. Treatment with TRAM-34 in vivo similarly reversed this facilitated effect of Ang II on the K Ca 3.1 current in primary cardiac fibroblasts. Figure 7B illustrates the mean values of the current-voltage relationships of the TRAM-34-sensitive current obtained by digital subtraction of the current before TRAM-34 from the current after addition of TRAM-34 to primary cardiac fibroblasts. The current-voltage curves of TRAM-34-sensitive current showed a weak inward rectification, a typical characteristic of the K Ca 3.1 channel current. The current density at À30 to +100 mV was enhanced in cells isolated from Ang II-infusion rats and significantly decreased by TRAM-34 treatment.
Interaction Between K Ca 3.1 and TRPV4/TRPC6 Channels in Rat Myocardium and Isolated Primary Cardiac Fibroblasts TRP channels have emerged as the primary ion channels mediating Ca 2+ signals in cardiac fibroblasts. 2 We then explored the possibility that an interaction between K Ca 3.1 and TRPV4 or TRPC6 channels exists in fibroblasts that regulates progression of cardiac fibrosis. This was examined by immunofluorescence double staining for expression and colocation of K Ca 3.1 with TRPV4 or TRPC6 channels in rat LV myocardium ( Figure 8A and 8B). Ang II infusion for 4 weeks significantly increased the expression of all 3 channels of K Ca 3.1, TRPV4, and TRPC6, and this was reversed by treatment with TRAM-34 in vivo. To determine whether the interaction among these channels appeared in fibroblasts, we stained the primary cardiac fibroblasts isolated from rat ventricle in each group. As shown in Figure 8C and 8D, the expressions of these channels in cardiac fibroblasts were comparable among different groups. The result from coimmunoprecipitation in healthy rat cardiac fibroblasts further demonstrated the physical interaction between K Ca 3.1 and TRPV4 or TRPC6 channels ( Figure S4 ).
Discussion
In the present study we demonstrated for the first time that blockade of K Ca 3.1 channels in rats subjected to chronic Ang II infusion inhibited cardiac fibrosis by alleviating myocardial inflammation and differentiation of bone marrow-derived monocytes to myofibroblasts in vivo. Ex vivo experiments further revealed that blockade or downregulation of K Ca 3.1 channels in CD4 + T cells suppressed Ang II-stimulated expression of IL-4 and IL-13 and halted IL-4-and IL-13-mediated differentiation of monocytes to fibrocytes. Ang II has been shown to induce cardiac fibrosis and remodeling through induction of hypertension and direct activation of its receptors localized at the myocardium. [22] [23] [24] In the current study on a rat model of cardiac fibrosis through chronic Ang II infusion, we observed typical changes of myocardial hypertrophy and fibrosis, manifested as increased heart weight and collagen synthesis and deposition as well as activation of collagen synthesis signaling. We confirmed the increment of SBP and decline in LV systolic function following Ang II treatment. Importantly, our data showed that all these changes were largely prevented by concomitant treatment with the K Ca 3.1 selective inhibitor TRAM-34, suggesting that K Ca 3.1 channels play an essential role in the development of cardiac fibrosis in this model. Inflammatory signaling is closely involved in the progression of cardiac fibrosis. 25 Ang II has been known to possess proinflammatory action in the setting of cardiovascular diseases by inducing vascular damage, upregulating adhesion molecules or cytokines, and increasing inflammatory cell infiltration as well as regulating repair processes. 26, 27 We previously showed, in the rat model of cardiac fibrosis as a consequence of abdominal aorta constriction, that enhanced expression of inflammatory cytokines and infiltration of inflammatory cells were efficiently attenuated by the treatment with TRAM-34. 14 In the current study on Ang II-infusion rats, we further confirmed the increase of TNF-a and MCP-1 expression in the myocardium and observed the increment of MCP-1 level in plasma. TNF-a, a pleiotropic cytokine, can facilitate the necrosis and apoptosis of cardiomyocytes and increase synthesis of ECM proteins, leading to fibrosis.
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There are studies showing that TNF-a also enhances the generation of monocytic fibroblast precursors in the heart. 29 MCP-1 plays a key role in regulating recruitment of monocytes and T lymphocytes. 3, 30 Haudek et al reported that cardiac fibrosis induced by Ang II infusion is dependent on the induction of MCP-1, which modulates the uptake and differentiation of a subpopulation of bone marrow-derived monocyte fibroblast precursor cells. 31, 32 Our recent investigation showed that an Ang II-induced increase of MCP-1 Figure 8 . Colocalization of K Ca 3.1 and TRP channels in left ventricle and isolated primary cardiac fibroblasts from Ang II-infusion rats.
A, Immunofluorescent double staining of K Ca 3.1 channels (red) and TRPV4 channels (green) in the myocardium (n=6, 9400). B, Immunofluorescent double staining of K Ca 3.1 channels (red) and TRPC6 channels (green) in the myocardium (n=6, 9400). C, Immunofluorescent double staining of K Ca 3.1 channels (red) and TRPV4 channels (green) in primary cardiac fibroblasts (n=6, 9400). D, Immunofluorescent double staining of K Ca 3.1 channels (red) and TRPC6 channels (green) in primary cardiac fibroblasts (n=6, 9400). Ang II indicates angiotensin II; TRPV4, transient receptor potential V4; TRPC6, transient receptor potential C6.
secretion in endothelium promoted the transendothelium migration of monocytes. 14 Therefore, the increment of MCP-1 plasma level in Ang II-treated rats was, at least in part, released from endothelial cells and likely contributed to the leukocyte recruitment into the myocardium. Hypertension induced by Ang II infusion facilitates the infiltration of leukocytes into the heart. The interactions among macrophages, T cells, and monocytic fibroblast precursor cells regulate the imbalance of proinflammatory and anti-inflammatory factors. [33] [34] [35] [36] In this study we found that the expressions of surface markers of leukocytes (CD45), T cells (CD3), and macrophages (CD68) were increased in the myocardium of Ang II-treated rats, implying that Ang II infusion promoted T lymphocyte and monocyte infiltration into the myocardium. We previously demonstrated that blockade of K Ca 3.1 channels with TRAM-34 attenuated pressure overload-induced cardiac fibrosis in vivo and prevented Ang II-stimulated fibroblast proliferation and monocyte transendothelium migration in vitro. 13, 14 However, whether K Ca 3.1 channels affect the Ang II infusion-induced increase of fibrocytes remains unexplored. In the present study we furthered previous findings by documenting that K Ca 3.1 channels play a key role in Ang IIinduced increase of fibrocytes in myocardium. 39 In our current research we provided evidence for K Ca 3.1 channels in promoting fibrocyte differentiation induced by IL-4 and IL-13 with cellular morphological alteration to elongated, spindle-shape. TRAM-34 and K Ca 3.1 siRNA can significantly decrease the number of spindle-shaped fibrocytes.
A critical event leading to cardiac fibrosis is the differentiation of cardiac fibroblasts into myofibroblasts. Myofibroblasts express contractile proteins such as a-SMA and have enhanced expression and secretion of ECM proteins. 43, 44 Recent studies have revealed that profibrotic mediators such as TGF-b and Ang II induce expression of TRPC6 in ventricular fibroblasts via p38 MAPK/serum-responsive factor. This in turn activates calcineurin/nuclear factor of activated T-cell signaling cascades that are involved in fibroblast proliferation and a-SMA expression. 45, 46 TRPV4 is also implicated in myofibroblast activation, which is governed by orchestrated signals from secreted growth factors (such as TGF-b) and mechanosensitive stimuli through a rho-rho-associated protein kinase signaling pathway. 47 The Ca 2+ influx through TRP channels is greatly influenced by cell membrane potential, which is controlled by K + channels. K Ca 3.1 channels are found to be expressed in nonexcitable cells and to be associated only with non-voltagegated Ca 2+ channels, such as TRP channels. The activation of K Ca 3.1 channels in fibroblasts and myofibroblasts induces a hyperpolarization, which increases Ca 2+ entry through TRP channels by enhancing the electrochemical gradient for Ca 2+ and leads to elevated intracellular Ca 2+ concentration. In this case K Ca 3.1 channels play a crucial role in this low-energy-cost and positive feedback loop. Interestingly, in Ang II-treated rat hearts we found an increased density of myofibroblasts that express K Ca 3.1 and TRPV4 or TRPC6 channels at higher levels. These cells also exhibit interaction between K Ca 3.1 and TRPV4 or TRPC6 channels, indicating that these channel proteins form channel complexes after chronic Ang II stimulation. Importantly, treatment with TRAM-34 reversed this phenomenon in vivo. Moreover, in fibroblasts isolated from hearts of rats subjected to Ang II infusion, the current density of K Ca 3.1 channels was increased, which was again attenuated by TRAM-34 treatment. These results strongly indicate that K Ca 3.1 channels couple with TRPV4 or TRPC6 channels and promote differentiation of myofibroblasts.
In conclusion, we have demonstrated that enhanced K Ca 3.1 channel activity was evident in fibroblasts from Ang II-treated hearts and that K Ca 3.1 channels in different types of cells play a critical role in the development of cardiac fibrosis. This action is mediated through its proinflammatory effect that facilitates the differentiation of bone marrowderived monocytes into fibrocytes and then through coupling with TRPV4 or TRPC6 channels to promote the differentiation of fibroblasts into myofibroblasts ( Figure 9 ). Treatment with the K Ca 3.1 channel inhibitor TRAM-34 alleviates cardiac fibrosis by Ang II infusion. Our findings imply that K Ca 3.1 channels may provide a potential therapeutic strategy to prevent or reverse cardiac fibrosis.
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